Zoledronic Acid for Prevention of Bone Loss in Patients Receiving Primary Therapy for Lymphomas: A Prospective, Randomized Controlled Phase III Trial by Westin, Jason R, Thompson, Michael A, Cataldo, Vince D, Fayad, Luis E, Fowler, Nathan, Fanale, Michelle A, Neelapu, Saatva, Samaniego, Felipe, Romaguera, Jorge, Shah, Jatin, McLaughlin, Peter, Pro, Barbara, Kwak, Larry W, Sanjorjo, Perpetua, Murphy, William A, Jimenez, Camillo, Toth, Bela, Dong, Wenli, Hagemeister, Fredrick B

Get full text

Gemcitabine, Fludarabine, and Melphalan for Reduced-Intensity Conditioning and Allogeneic Stem Cell Transplantation for Relapsed and Refractory Hodgkin Lymphoma by Anderlini, Paolo, Saliba, Rima M, Ledesma, Celina, Plair, Tamera, Alousi, Amin M, Hosing, Chitra M, Khouri, Issa F, Nieto, Yago, Popat, Uday R, Shpall, Elizabeth J, Fanale, Michelle A, Hagemeister, Frederick B, Oki, Yasuhiro, Neelapu, Saatva, Romaguera, Jorge E, Younes, Anas, Champlin, Richard E

Get full text